Nemifitide (diTFA)

• Description:

  Nemifitide diTFA (INN 00835 diTFA) is a synthetic pentapeptide antidepressant with a potential for rapid onset of action[1]. Nemifitide diTFA is a peptide analog of melanocyte-inhibiting factor (MIF) [2]. Nemifitide diTFA can cross the blood-brain barrier[3].

• Product Name Alternative:

  INN 00835 (diTFA)

• UNSPSC:

  12352209

• Target:

  5-HT Receptor

• Type:

  Peptides

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/nemifitide-ditfa.html

• Purity:

  98.24

• Solubility:

  H2O : 250 mg/mL (ultrasonic)

• Smiles:

  FC (C=C1) =CC=C1C[C@H] (N) C (N2[C@@H] (C[C@@H] (O) C2) C (N[C@@H] (CCCNC (N) =N) C (NCC (N[C@H] (C (N) =O) CC3=CNC4=C3C=CC=C4) =O) =O) =O) =O.O=C (O) C (F) (F) F.O=C (O) C (F) (F) F

• Molecular Formula:

  C37H45F7N10O10

• Molecular Weight:

  922.80

• References & Citations:

  [1]Kelly JP, et al. The effect of treatment with a new antidepressant, INN 00835, on platelet serotonin uptake in depressed patients. J Affect Disord. 1999 Oct;55 (2-3) :231-5.|[2]Overstreet DH, et al. Antidepressant-like effects of a novel pentapeptide, nemifitide, in an animal model of depression. Psychopharmacology (Berl) . 2004 Sep;175 (3) :303-9.|[3]Montgomery SA, et al. Efficacy and safety of 30 mg/d and 45 mg/d nemifitide compared to placebo in major depressivedisorder. Int J Neuropsychopharmacol. 2006 Oct;9 (5) :517-28.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light)

• Scientific Category:

  Peptides

• Clinical Information:

  Phase 2

• CAS Number:

  204992-09-6